Similarly, IDH2 inhibition in IDH2 mutant leukemia cells elicited a leukemic cell differentiation response, suggesting another avenue that could reverse the differentiation block observed in AML [203]. This evidence concerns the gene IDH2 and acute myeloid leukemia.